Ivermectin Albendazole Suspension Franchise in Ahmedabad

Ivermectin Albendazole Suspension Supplier in Mumbai

Ivermectin Albendazole Suspension Distributor in Delhi

Anthelmintic Suspension Franchise Opportunity in Bangalore

Ivermectin Albendazole Suspension Stockist in Hyderabad
Ivermectin Albendazole Suspension Export & Manufacturing in Chandigarh

Home/Products /ivermectin-3mg-albendazole-200mg

Womturn I Suspension

Composition : Ivermectin (3mg) + Albendazole (200mg) Syrup

Dosage Form : Suspension

Packaging Type : Bottle

Packaging : 10ml

Price : ₹65/-

Contact For Business Query

Womturn I Suspension contains Ivermectin 3mg + Albendazole 200mg, a well-established combination used in the treatment of intestinal parasitic and worm infestations. It is commonly prescribed for roundworms, hookworms, threadworms, and mixed helminthic infections in pediatric and adult patients.

Albendazole works by inhibiting parasite glucose uptake, leading to energy depletion and death of worms, while Ivermectin enhances antiparasitic action by causing paralysis of parasites. This dual-action approach improves treatment efficacy and reduces recurrence risk.

The suspension form ensures ease of administration, accurate dosing, and better patient compliance, especially in children. Due to its wide clinical acceptance and routine use in deworming programs, this combination maintains consistent market demand.

Adding Womturn I Suspension to your anthelmintic and antiparasitic segment strengthens your portfolio with a high-rotation product. Its broad therapeutic application, prescriber trust, and export suitability make it a strong choice for PCD pharma companies, distributors, and third-party manufacturing partners.

Read More

About the Product

Womturn I Suspension contains Ivermectin 3mg + Albendazole 200mg, a well-established combination used in the treatment of intestinal parasitic and worm infestations. It is commonly prescribed for roundworms, hookworms, threadworms, and mixed helminthic infections in pediatric and adult patients.

Albendazole works by inhibiting parasite glucose uptake, leading to energy depletion and death of worms, while Ivermectin enhances antiparasitic action by causing paralysis of parasites. This dual-action approach improves treatment efficacy and reduces recurrence risk.

The suspension form ensures ease of administration, accurate dosing, and better patient compliance, especially in children. Due to its wide clinical acceptance and routine use in deworming programs, this combination maintains consistent market demand.

Adding Womturn I Suspension to your anthelmintic and antiparasitic segment strengthens your portfolio with a high-rotation product. Its broad therapeutic application, prescriber trust, and export suitability make it a strong choice for PCD pharma companies, distributors, and third-party manufacturing partners.

Common side effects may include nausea, vomiting, abdominal pain, dizziness, or mild headache. Rare but serious side effects include allergic reactions, liver function disturbances, or neurological symptoms. Medical attention should be sought if severe or unusual symptoms occur.

Womturn I Suspension is indicated for the treatment of intestinal helminthic infections such as roundworm, hookworm, pinworm, threadworm, and strongyloidiasis, as prescribed by a healthcare professional.

Womturn I Suspension should be taken exactly as prescribed, and the dose should be measured carefully using a calibrated measuring device. Caution is advised in patients with liver disease or neurological disorders. Repeat dosing, if required, should only be done on medical advice.

Store Womturn I Suspension in a cool, dry place away from direct sunlight. Keep out of reach of children, shake well before use, and do not use beyond the expiry date printed on the label.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation

@2024 | copy rights by Cafoli